Physician Investigator (Cl)
Mass General Research Institute
anti-anxiety agents; anticonvulsants; anxiety disorders; bipolar disorder; depression; passiflora; patient dropouts; piracetam; treatment-resistant depression
Dr. Kinrys is an investigator on studies funded by the National Institutes of Mental Health and the Agency for Healthcare Research and Quality involving the course of Bipolar disorder and Major depressive disorder. He is also an investigator in numerous phase I, phase II, and phase III clinical trials sponsored by the pharmaceutical industry. He has published over 100 articles, reviews and posters and he lectures in national and international forums. Dr. Kinrys has been the principal investigator in over 80 clinical trials. His areas of interest include treatment resistant depression, bipolar and anxiety disorders, development of novel pharmacologic agents for mood and anxiety disorders, cross-cultural and minority issues in clinical trials, and uses of natural remedies alone and combined with conventional pharmacologic therapies for treatment-refractory patients.